跳至主要内容
临床试验/DRKS00028604
DRKS00028604已完成未知

System accuracy evaluation of 4 blood glucose monitoring systems based on ISO 15197:2013 / EN ISO 15197:2015 - IfDT-2172(2)-AB

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)0 个研究点目标入组 113 人开始时间: 2022年3月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
113

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed informed consent form
  • - Subjects are legally competent and capable to understand character, meaning and consequences of the study.
  • - If blood glucose values < 80 mg/dl or > 300 mg/dl shall be measured after short term alteration in insulin therapy:
  • - Male or female with type 1 diabetes and intensified insulin therapy or insulin pump therapy.
  • - Signature of subjects to document consent with these procedures on informed consent form.

排除标准

  • - Pregnancy or lactation period if venous samples are needed
  • - Severe acute disease that compromises the subject’s capability to participate in the study (at the study physician’s discretion)
  • - Severe chronic disease with potential risk during the test procedures (at the study physician’s discretion)
  • - Medical relevant anemia
  • - Suspected lack of compliance
  • - Dependence on investigator or sponsor
  • - If blood glucose values < 80 mg/dl shall be measured after short term alteration in insulin therapy:
  • - Pregnancy or lactation period
  • - Subjects with type 1 diabetes, suffering from
  • - Coronary heart disease
  • - Condition after myocardial infarction
  • - Condition after cerebral events
  • - Peripheral arterial occlusive disease
  • - Hypoglycemia unawareness

研究者

发起方
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)

相似试验